CIK 0001937993 · <br>Emerging growth company
Cadrenal Therapeutics, Inc.
Sign in to watch- Ticker
- CVKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880860746
- Phone
- 904-300-0701
- Business address
- 822 A1A NORTH, SUITE 306, PONTE VEDRA, FL, 32082
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-01 | Pham Quang X CEO and Chairman | Sale 10b5-1 | −881 | $14.01 | $12K | 202,633 |
| 2025-09-29 | Szot Matthew K Chief Financial Officer | Sale 10b5-1 | −100 | $14.00 | $1K | 18,833 |
| 2025-09-29 | Pham Quang X CEO and Chairman | Sale 10b5-1 | −419 | $14.01 | $6K | 203,514 |
| 2025-09-25 | Szot Matthew K Chief Financial Officer | Sale 10b5-1 | −10,900 | $14.05 | $153K | 18,933 |
| 2025-09-25 | Pham Quang X CEO and Chairman | Sale 10b5-1 | −6,790 | $14.09 | $96K | 203,933 |
| 2025-09-24 | Szot Matthew K Chief Financial Officer | Sale 10b5-1 | −1,500 | $14.00 | $21K | 29,833 |
| 2025-09-24 | Pham Quang X CEO and Chairman | Sale 10b5-1 | −2,581 | $13.99 | $36K | 210,723 |
| 2025-08-28 | Szot Matthew K Chief Financial Officer | Sale 10b5-1 | −400 | $14.00 | $6K | 31,333 |
| 2025-08-28 | Pham Quang X CEO and Chairman | Sale 10b5-1 | −1,193 | $13.99 | $17K | 213,304 |
| 2025-08-27 | Szot Matthew K Chief Financial Officer | Sale 10b5-1 | −1,600 | $14.00 | $22K | 31,733 |
| 2025-08-27 | Pham Quang X CEO and Chairman | Sale 10b5-1 | −3,836 | $13.99 | $54K | 214,497 |
| 2025-02-05 | Ferguson James J. III Chief Medical Officer | Grant or award · Stock Options | +60,000 | 60,000 | ||
| 2025-01-23 | Pham Quang X CEO and Chairman | Grant or award · Stock Options | +65,000 | 65,000 | ||
| 2025-01-23 | MURPHY JOHN RAYMOND Director | Grant or award · Stock Options | +20,000 | 20,000 | ||
| 2025-01-23 | WILSON GLYNN Director | Grant or award · Stock Options | +20,000 | 20,000 | ||
| 2025-01-23 | Zelenkofske Steven Director | Grant or award · Stock Options | +20,000 | 20,000 | ||
| 2025-01-23 | Cole Jeffrey Scott Chief Operating Officer | Grant or award · Stock Options | +25,000 | 25,000 | ||
| 2025-01-23 | Szot Matthew K Chief Financial Officer | Grant or award · Stock Options | +50,000 | 50,000 | ||
| 2025-01-23 | Pham Quang X CEO and Chairman | Grant or award · Stock Options | +65,000 | 65,000 | ||
| 2025-01-23 | Lisicki Robert Director | Grant or award · Stock Options | +20,000 | 20,000 |
Page 3 of 5 · 88 trades